| A muscle-liver-fat signalling axis is essential for central control of adaptive adipose remodelling N Shimizu, T Maruyama, N Yoshikawa, R Matsumiya, Y Ma, N Ito, ... Nature communications 6 (1), 6693, 2015 | 145 | 2015 |
| SOX9 is essential for triple-negative breast cancer cell survival and metastasis Y Ma, J Shepherd, D Zhao, LR Bollu, WM Tahaney, J Hill, Y Zhang, ... Molecular Cancer Research 18 (12), 1825-1838, 2020 | 63 | 2020 |
| An anticancer effect of a new saponin component from Gymnocladus chinensis Baillon through inactivation of nuclear factor-κB Ma, Y.X., H.Z. Fu, M. Li, W. Sun, B. Xu and J.R. Cui Anti-cancer drugs 18 (1), 41-46, 2007 | 27 | 2007 |
| Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1 LR Bollu, J Shepherd, D Zhao, Y Ma, W Tahaney, C Speers, A Mazumdar, ... NPJ Breast cancer 6 (1), 2, 2020 | 22 | 2020 |
| In vitro anticancer property of a novel thalidomide analogue through inhibition of NF-κB activation in HL-60 cells M Li, W Sun, Y Yang, B Xu, W Yi, Y Ma, Z Li, J Cui Acta Pharmacologica Sinica 30 (1), 134-140, 2009 | 22 | 2009 |
| 以 NF-_κB 为靶的药物筛选方法的建立与应用研究 马艳霞， 徐波， 崔景荣， 王鹂， 吴军， 李敏 生物化学与生物物理进展 33 (2), 149-154, 2006 | 9 | 2006 |
| Abstract P1-08-04: SOX9 is a critical regulator of triple-negative breast cancer cell growth and invasion Y Ma, J Shepherd, A Mazumdar, D Zhao, L Bollu, J Hill, Y Zhang, P Brown Cancer Research 77 (4_Supplement), P1-08-04-P1-08-04, 2017 | 4 | 2017 |
| Targeting the mTOR pathway for the prevention of ER-negative breast cancer A Mazumdar, WM Tahaney, JL Hill, Y Zhang, S Ramachandran, ... Cancer Prevention Research 15 (12), 791-802, 2022 | 3 | 2022 |
| The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth J Qian, Y Ma, WM Tahaney, CL Moyer, A Lanier, J Hill, D Coleman, ... Breast Cancer Research 26 (1), 23, 2024 | 2 | 2024 |
| Abstract GS1-09: Inhibition of GPX4 induces preferential death of p53-mutant triple-negative breast cancer cells WM Tahaney, J Qian, R Powell, CL Moyer, Y Ma, N Nguyen, J Hill, ... Cancer Research 82 (4_Supplement), GS1-09-GS1-09, 2022 | 2 | 2022 |
| SOX9 is a critical regulator of triple-negative breast cancer growth and invasion Y Ma, J Shepherd, D Zhao, L Bollu, J Hill, Y Zhang, A Mazumdar, ... Cancer Research 78 (13_Supplement), 3347-3347, 2018 | 2 | 2018 |
| NF-κB 与肿瘤防治药物研究进展 马艳霞， 李敏 肿瘤防治研究 33 (06), 465-467, 2006 | 2 | 2006 |
| SOX9 controls TNBC growth and metastasis via regulating the expression of apoptosis and EMT genes Y Ma, L Bollu, J Hill, Y Zhang, WM Tahaney, A Mazumdar, PH Brown Cancer Research 79 (13_Supplement), 2618-2618, 2019 | 1 | 2019 |
| Inhibition of GPX4 Induces the Death of p53-Mutant Triple-Negative Breast Cancer Cells WM Tahaney, J Qian, A Lanier, CL Moyer, N Nguyen, Y Ma, J Hill, ... | | 2024 |
| Abstract PO2-24-01: Kif11 Inhibition Preferentially Kills TP53-mutant Breast Cancer Cells A Lanier, W Tahaney, J Qian, C Moyer, Y Ma, B Arun, A Mazumdar, ... Cancer Research 84 (9_Supplement), PO2-24-01-PO2-24-01, 2024 | | 2024 |
| TP53mutations promote death of breast cancer cells following Kif11 inhibition AL Lanier, W Tahaney, J Qian, C Moyer, Y Ma, B Arun, A Mazumdar, ... Cancer Research 84 (6_Supplement), 522-522, 2024 | | 2024 |
| Targeting S100A10, a SOX9 binding protein, for the treatment of triple negative breast cancer Y Ma, J Qian, C Moyer, A Lanier, J Hill, D Coleman, DH Hawke, ... Cancer Research 83 (7_Supplement), 3966-3966, 2023 | | 2023 |
| SOX9-binding proteins regulate SOX9 activity to control the growth of triple-negative breast cancer cells Y Ma, DH Hawke, G Manyam, W Wang, A Mazumdar, P Brown Cancer Research 82 (12_Supplement), 2368-2368, 2022 | | 2022 |
| Inhibition of GPX4 Induces the Death of p53-Mutant Triple-Negative Breast Cancer WM Tahaney, J Qian, CL Moyer, N Nguyen, A Lanier, Y Ma, J Hill, ... | | 2022 |
| Abstract P5-12-08: The role of a novel phosphatase NUDT5 in triple-negative breast cancer J Qian, W Tahaney, Y Ma, A Mazumdar, P Brown Cancer Research 82 (4_Supplement), P5-12-08-P5-12-08, 2022 | | 2022 |
